Dimer models for ErbB-2/neu transmembrane domains from molecular dynamics simulations

被引:13
|
作者
Sajot, N [1 ]
Garnier, N [1 ]
Genest, M [1 ]
机构
[1] Univ Orleans, UPR 4301 CNRS, Ctr Biophys Mol, F-45071 Orleans 02, France
关键词
ErbB-2/neu transmembrane domains; molecular dynamic simulations; helix-helix association; pi helix deformations;
D O I
10.1007/s002140050408
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Interest in the transmembrane receptors tyrosine kinase of the erbB family is high due to the involvement of some of the members in human cancers. The original oncogenic alleles of neu discovered in rat neuroectodermal tumors lead to single Va1664Glu substitution within the predicted transmembrane domain: Identical substitution at the homologous position 659 constitutively activates the oncogenic potential of the human ErbB-2 receptor by enhanced receptor dimer formation. The precise molecular details of receptor dimerization are still unknown and to acquire more knowledge of the mechanisms involved, molecular dynamics simulations are undertaken to study transmembrane dimer association. Transmembrane helices are predicted to associate in left-handed coiled-coil structures stabilized by Glu-Glu interhelix hydrogen bonds in the mutated form. The internal dynamics reveals pi helix deformations which modify the helix-helix interface. Predicted models agree with those suggested from polarized IR and magic-angle spinning NMR spectroscopy.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [31] Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer
    Aller, P
    Voiry, L
    Garnier, N
    Genest, M
    BIOPOLYMERS, 2005, 77 (04) : 184 - 197
  • [32] Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro
    Hevér, A
    Oshima, RG
    Hauser, CA
    EXPERIMENTAL CELL RESEARCH, 2003, 290 (01) : 132 - 143
  • [33] erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer
    Lai, GH
    Zhang, ZC
    Shen, XN
    Ward, DJ
    Dewitt, JL
    Holt, SE
    Rozich, RA
    Hixson, DC
    Sirica, AE
    GASTROENTEROLOGY, 2005, 129 (06) : 2047 - 2057
  • [34] Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors
    Chan, R
    Muller, WJ
    Siegel, PM
    CANCER PREVENTION: NOVEL NUTRIENT AND PHARMACEUTICAL DEVELOPMENTS, 1999, 889 : 45 - 51
  • [35] Genetic identification of effectors downstream of Neu (ErbB-2) autophosphorylation sites in a Drosophila model
    Mark Settle
    Michael D Gordon
    Mythili Nadella
    David Dankort
    William Muller
    J Roger Jacobs
    Oncogene, 2003, 22 : 1916 - 1926
  • [36] Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells
    Shida, D
    Kitayama, J
    Yamaguchi, H
    Yamashita, H
    Mori, K
    Watanabe, T
    Nagawa, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (03) : 907 - 914
  • [37] RARE OCCURRENCE OF AMPLIFICATION OF ERBB-2(HER-2/NEU) ONCOGENE IN OVARIAN CARCINOMAS
    IMYANITOV, EN
    CHERNITSA, OI
    SEROVA, OM
    YURKOVA, LE
    VINOKUROV, VL
    KNYAZEV, PG
    EKSPERIMENTALNAYA ONKOLOGIYA, 1992, 14 (01): : 43 - 45
  • [38] Effect of γ-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene
    Menendez, JA
    Vellon, L
    Colomer, R
    Lupu, R
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (21): : 1611 - 1615
  • [39] AMPLIFICATION AND EXPRESSION OF THE NEU/ERBB-2 PROTONCOGENE IN HUMAN PRIMARY BREAST-CARCINOMA
    DATI, C
    MURACA, R
    TAZARTES, O
    GIAI, M
    DEFABIANI, E
    SISMONDI, P
    SAGLIO, G
    DEBORTOLI, M
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 110 - 110
  • [40] CLONING, EXPRESSION, AND BIOLOGICAL EFFECTS OF ERBB-2/NEU GENE IN MAMMALIAN-CELLS
    DIFIORE, PP
    SEGATTO, O
    AARONSON, SA
    METHODS IN ENZYMOLOGY, 1991, 198 : 272 - 277